Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Pfenex Inc. (PFNX)

13.35   0.25 (1.91%) 02-14 16:00
Open: 13.47 Pre. Close: 13.1
High: 13.9093 Low: 13.08
Volume: 419,789 Market Cap: 423M
Pfenex Inc is a clinical-stage biotechnology company. It is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and difficult-to-manufacture proteins.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.927 - 13.98 13.98 - 14.034
Low: 12.944 - 13.006 13.006 - 13.068
Close: 13.249 - 13.345 13.345 - 13.44

Technical analysis

as of: 2020-02-14 4:31:36 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 16.29     One year: 19.03
Support: Support1: 11.69    Support2: 10.29
Resistance: Resistance1: 13.95    Resistance2: 16.29
Pivot: 11.97
Moving Average: MA(5): 12.93     MA(20): 11.84
MA(100): 10.51     MA(250): 8.06
MACD: MACD(12,26): 0.37     Signal(9): 0.19
Stochastic oscillator: %K(14,3): 88.14     %D(3): 85.42
RSI: RSI(14): 63.51
52-week: High: 13.95  Low: 3.95  Change(%): 223.2
Average Vol(K): 3-Month: 32932  10-Days: 48021

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PFNX has closed below upper band by 11.2%. Bollinger Bands are 43.4% wider than normal. The large width of the bands suggest high volatility as compared to PFNX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Pfenex (PFNX) Matches Q3 Earnings Estimates
Pfenex (PFNX) delivered earnings and revenue surprises of 0.00% and 3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Pfenex (PFNX) Reports Next Week: Wall Street Expects Earnings Growth
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 31.68
Shares Float (M) 29.27
% Held by Insiders 0.45
% Held by Institutions 88.45
Shares Short (K) 604
Shares Short P. Month (K)

Stock Financials

EPS -0.480
Book Value (p.s.) 1.770
PEG Ratio -5.30
Profit Margin -47.31
Operating Margin -48.24
Return on Assets (ttm) -12.1
Return on Equity (ttm) -24.4
Qtrly Rev. Growth 327.1
Gross Profit (p.s.) 0.311
Sales Per Share
EBITDA (p.s.) -0.427
Qtrly Earnings Growth
Operating Cash Flow (M) -34.04
Levered Free Cash Flow (M) -29.41

Stock Valuations

P/E -27.81
P/E Growth Ratio 0.02
P/BV 7.54
P/S 13.21
P/CF -12.42

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.